Skip to main content
Erschienen in: Clinical Rheumatology 1/2016

01.01.2016 | Case Based Review

Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature

verfasst von: Sepideh Faez, Ann-Marie Lobo, Sebastian H. Unizony, John H. Stone, George N. Papaliodis, Lucia Sobrin

Erschienen in: Clinical Rheumatology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Scleritis and uveitis are potentially blinding conditions that can be associated with systemic inflammatory diseases. Polymyalgia rheumatica (PMR) is a common rheumatic disorder of the elderly of uncertain etiology. Although there are a few published reports of scleritis and uveitis in PMR patients, the association of PMR to ocular inflammation has not been well established. The aim of this study is to report a series of PMR patients with scleritis and/or uveitis and review the prior published reports of this potential association. We retrospectively reviewed the medical charts of patients with PMR and scleritis or uveitis who were examined in the Ocular Immunology Service of Massachusetts Eye and Ear Infirmary. We also performed a systematic literature search (PubMed; January 1990 until January 2014) to identify earlier published reports. Seven PMR patients with ocular inflammatory disease (OID) were included in our study: two with scleritis, three with anterior uveitis, and two with panuveitis. The onset of PMR preceded the occurrence of OID in six patients, and in one patient uveitis developed 2 months prior to PMR. Five patients demonstrated a temporal association between flares of PMR and OID. In four patients, OID flares developed during tapering of systemic prednisone prescribed for PMR. Four of the five patients who had relapsing PMR had recurrent or persistent uveitis over the course of follow-up. PMR may be associated with both scleritis and uveitis and should be considered as a possible underlying cause of OID.
Literatur
1.
Zurück zum Zitat Hamideh F, Prete PE (2001) Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 30(4):217–241PubMedCrossRef Hamideh F, Prete PE (2001) Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 30(4):217–241PubMedCrossRef
2.
Zurück zum Zitat McCluskey P, Powell RJ (2004) The eye in systemic inflammatory diseases. Lancet 364(9451):2125–2133PubMedCrossRef McCluskey P, Powell RJ (2004) The eye in systemic inflammatory diseases. Lancet 364(9451):2125–2133PubMedCrossRef
3.
Zurück zum Zitat Doran MF, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE (2002) Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol 29(8):1694–1697PubMed Doran MF, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE (2002) Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol 29(8):1694–1697PubMed
4.
Zurück zum Zitat Soriano A, Landolfi R, Manna R (2012) Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol 26(1):91–104PubMedCrossRef Soriano A, Landolfi R, Manna R (2012) Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol 26(1):91–104PubMedCrossRef
5.
Zurück zum Zitat Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347(4):261–271PubMedCrossRef Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347(4):261–271PubMedCrossRef
6.
Zurück zum Zitat Bandini F, Benedetti L, Ceppa P, Corallo G (2005) Uveitis as a presenting sign of giant cell arteritis. J Neuroophthalmol 25(3):247–248PubMedCrossRef Bandini F, Benedetti L, Ceppa P, Corallo G (2005) Uveitis as a presenting sign of giant cell arteritis. J Neuroophthalmol 25(3):247–248PubMedCrossRef
7.
Zurück zum Zitat Dasgupta B, Pitzalis C, Panayi GS (1989) Inflammation of the uveal tract as a presenting feature of temporal arteritis. Ann Rheum Dis 48(11):964–965PubMedPubMedCentralCrossRef Dasgupta B, Pitzalis C, Panayi GS (1989) Inflammation of the uveal tract as a presenting feature of temporal arteritis. Ann Rheum Dis 48(11):964–965PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Rajesh CV, Cole M (2000) Panuveitis as a presenting feature of giant cell arteritis. Br J Ophthalmol 84(3):340PubMed Rajesh CV, Cole M (2000) Panuveitis as a presenting feature of giant cell arteritis. Br J Ophthalmol 84(3):340PubMed
9.
Zurück zum Zitat Coppeto JR, Monteiro ML, Sciarra R (1985) Giant-cell arteritis with bilateral uveitic glaucoma. Ann Ophthalmol 17(5):299–302PubMed Coppeto JR, Monteiro ML, Sciarra R (1985) Giant-cell arteritis with bilateral uveitic glaucoma. Ann Ophthalmol 17(5):299–302PubMed
10.
Zurück zum Zitat Long RG, Friedmann AI, James DG (1976) Scleritis and temporal arteritis. Postgrad Medl J 52(613):689–692CrossRef Long RG, Friedmann AI, James DG (1976) Scleritis and temporal arteritis. Postgrad Medl J 52(613):689–692CrossRef
12.
13.
Zurück zum Zitat Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 65(8):1093–1098PubMedPubMedCentralCrossRef Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 65(8):1093–1098PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Takano T, Okisaka S, Hamanaka T, Ishida T, Hara J (1990) A case of necrotizing scleritis with angiitis of papilla. Nihon Ganka Gakkai Zasshi 94(4):424–431PubMed Takano T, Okisaka S, Hamanaka T, Ishida T, Hara J (1990) A case of necrotizing scleritis with angiitis of papilla. Nihon Ganka Gakkai Zasshi 94(4):424–431PubMed
15.
16.
Zurück zum Zitat Simmons IG, Kritzinger EE, Murray PI (1997) Posterior scleritis and polymyalgia rheumatica. Eye (Lond) 11(Pt 5):727–728CrossRef Simmons IG, Kritzinger EE, Murray PI (1997) Posterior scleritis and polymyalgia rheumatica. Eye (Lond) 11(Pt 5):727–728CrossRef
17.
Zurück zum Zitat Tsuda H, Tanaka K, Kishida S (2011) Anterior uveitis as an initial manifestation of polymyalgia rheumatica. Case Rep Med 2011:621241PubMedPubMedCentral Tsuda H, Tanaka K, Kishida S (2011) Anterior uveitis as an initial manifestation of polymyalgia rheumatica. Case Rep Med 2011:621241PubMedPubMedCentral
18.
Zurück zum Zitat Asensio Sanchez VM, Botella Oltra G, Carrasco E (2004) Biphosphonates and intraocular inflammation. Arch Soc Esp Oftalmol 79(2):85–87PubMedCrossRef Asensio Sanchez VM, Botella Oltra G, Carrasco E (2004) Biphosphonates and intraocular inflammation. Arch Soc Esp Oftalmol 79(2):85–87PubMedCrossRef
19.
Zurück zum Zitat Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM (1993) Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 36(9):1286–1294PubMedCrossRef Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM (1993) Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 36(9):1286–1294PubMedCrossRef
20.
Zurück zum Zitat Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ (1999) Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 159(6):577–584PubMedCrossRef Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ (1999) Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 159(6):577–584PubMedCrossRef
21.
Zurück zum Zitat Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M, Catanoso MG, Pulsatelli L, Meliconi R, Boiardi L (2005) Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 53(1):33–38PubMedCrossRef Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M, Catanoso MG, Pulsatelli L, Meliconi R, Boiardi L (2005) Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 53(1):33–38PubMedCrossRef
22.
Zurück zum Zitat Alvarez-Rodriguez L, Lopez-Hoyos M, Mata C, Marin MJ, Calvo-Alen J, Blanco R, Aurrecoechea E, Ruiz-Soto M, Martinez-Taboada VM (2010) Circulating cytokines in active polymyalgia rheumatica. Ann Rheum Dis 69(1):263–269PubMedCrossRef Alvarez-Rodriguez L, Lopez-Hoyos M, Mata C, Marin MJ, Calvo-Alen J, Blanco R, Aurrecoechea E, Ruiz-Soto M, Martinez-Taboada VM (2010) Circulating cytokines in active polymyalgia rheumatica. Ann Rheum Dis 69(1):263–269PubMedCrossRef
23.
Zurück zum Zitat Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33(1):38–48PubMedCrossRef Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33(1):38–48PubMedCrossRef
24.
Zurück zum Zitat Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C (2006) Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 33(4):703–708PubMed Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C (2006) Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 33(4):703–708PubMed
26.
Zurück zum Zitat Kramer M, Monselise Y, Bahar I, Cohen Y, Weinberger D, Goldenberg-Cohen N (2007) Serum cytokine levels in active uveitis and remission. Curr Eye Res 32(7–8):669–675PubMedCrossRef Kramer M, Monselise Y, Bahar I, Cohen Y, Weinberger D, Goldenberg-Cohen N (2007) Serum cytokine levels in active uveitis and remission. Curr Eye Res 32(7–8):669–675PubMedCrossRef
27.
Zurück zum Zitat Perez VL, Papaliodis GN, Chu D, Anzaar F, Christen W, Foster CS (2004) Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm 12(3):193–201PubMedCrossRef Perez VL, Papaliodis GN, Chu D, Anzaar F, Christen W, Foster CS (2004) Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm 12(3):193–201PubMedCrossRef
28.
Zurück zum Zitat de Boer JH, van Haren MA, de Vries-Knoppert WA, Baarsma GS, de Jong PV, Postema FJ, Rademakers AJ, Kijlstra A (1992) Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res 11(Suppl):181–186PubMedCrossRef de Boer JH, van Haren MA, de Vries-Knoppert WA, Baarsma GS, de Jong PV, Postema FJ, Rademakers AJ, Kijlstra A (1992) Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res 11(Suppl):181–186PubMedCrossRef
29.
Zurück zum Zitat Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13(6):711–718PubMedCrossRef Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13(6):711–718PubMedCrossRef
30.
Zurück zum Zitat Yoshimura T, Sonoda KH, Miyazaki Y, Iwakura Y, Ishibashi T, Yoshimura A, Yoshida H (2008) Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol 20(2):209–214PubMedCrossRef Yoshimura T, Sonoda KH, Miyazaki Y, Iwakura Y, Ishibashi T, Yoshimura A, Yoshida H (2008) Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol 20(2):209–214PubMedCrossRef
31.
Zurück zum Zitat Weyand CM, Younge BR, Goronzy JJ (2011) IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol 23(1):43–49PubMedPubMedCentralCrossRef Weyand CM, Younge BR, Goronzy JJ (2011) IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol 23(1):43–49PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441(7090):231–234PubMedCrossRef Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441(7090):231–234PubMedCrossRef
33.
Zurück zum Zitat Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235–238PubMedCrossRef Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235–238PubMedCrossRef
34.
Zurück zum Zitat Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T (2011) Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 52(6):3264–3271PubMedCrossRef Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T (2011) Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 52(6):3264–3271PubMedCrossRef
35.
Zurück zum Zitat Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, Stone JR, Stone JH (2012) Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken) 64(11):1720–1729PubMedCrossRef Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, Stone JR, Stone JH (2012) Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken) 64(11):1720–1729PubMedCrossRef
36.
Zurück zum Zitat Macchioni P, Boiardi L, Catanoso M, Pulsatelli L, Pipitone N, Meliconi R, Salvarani C (2013) Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum 43(1):113–118PubMedCrossRef Macchioni P, Boiardi L, Catanoso M, Pulsatelli L, Pipitone N, Meliconi R, Salvarani C (2013) Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum 43(1):113–118PubMedCrossRef
37.
Zurück zum Zitat Muselier A, Bielefeld P, Bidot S, Vinit J, Besancenot JF, Bron A (2011) Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis. Ocul Immunol Inflamm 19(5):382–383PubMedCrossRef Muselier A, Bielefeld P, Bidot S, Vinit J, Besancenot JF, Bron A (2011) Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis. Ocul Immunol Inflamm 19(5):382–383PubMedCrossRef
38.
Zurück zum Zitat Tappeiner C, Heinz C, Ganser G, Heiligenhaus A (2012) Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? J Rheumatol 39(6):1294–1295PubMedCrossRef Tappeiner C, Heinz C, Ganser G, Heiligenhaus A (2012) Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? J Rheumatol 39(6):1294–1295PubMedCrossRef
39.
Zurück zum Zitat Moosig F, Czech N, Mehl C, Henze E, Zeuner RA, Kneba M, Schroder JO (2004) Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 63(7):870–873PubMedPubMedCentralCrossRef Moosig F, Czech N, Mehl C, Henze E, Zeuner RA, Kneba M, Schroder JO (2004) Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 63(7):870–873PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, Bobbaers H, Mortelmans L (1999) New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38(5):444–447CrossRef Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, Bobbaers H, Mortelmans L (1999) New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38(5):444–447CrossRef
41.
Zurück zum Zitat Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125(4):509–520PubMedCrossRef Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125(4):509–520PubMedCrossRef
42.
Zurück zum Zitat Fong LP, Sainz de la Maza M, Rice BA, Kupferman AE, Foster CS (1991) Immunopathology of scleritis. Ophthalmology 98(4):472–479PubMedCrossRef Fong LP, Sainz de la Maza M, Rice BA, Kupferman AE, Foster CS (1991) Immunopathology of scleritis. Ophthalmology 98(4):472–479PubMedCrossRef
43.
Zurück zum Zitat Mackie SL, Pease CT (2013) Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips. Postgrad Med J 89(1051):284–292PubMedCrossRef Mackie SL, Pease CT (2013) Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips. Postgrad Med J 89(1051):284–292PubMedCrossRef
44.
Zurück zum Zitat Darrell RW, Wagener HP, Kurland LT (1962) Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol 68:502–514PubMedCrossRef Darrell RW, Wagener HP, Kurland LT (1962) Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol 68:502–514PubMedCrossRef
45.
Zurück zum Zitat Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, Alberts C, Luyendijk L, Kijlstra A (1992) Uveitis and systemic disease. Br J Ophthalmol 76(3):137–141PubMedPubMedCentralCrossRef Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, Alberts C, Luyendijk L, Kijlstra A (1992) Uveitis and systemic disease. Br J Ophthalmol 76(3):137–141PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80(4):332–336PubMedPubMedCentralCrossRef Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80(4):332–336PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Saari KM, Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, Sillanpaa M (1995) Epidemiology of endogenous uveitis in south-western Finland. Acta Ophthalmol Scand 73(4):345–349PubMedCrossRef Saari KM, Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, Sillanpaa M (1995) Epidemiology of endogenous uveitis in south-western Finland. Acta Ophthalmol Scand 73(4):345–349PubMedCrossRef
48.
Zurück zum Zitat Boyd M, Specks U, Finkielman JD (2010) Accuracy of the ICD-9 code for identification of patients with Wegener's granulomatosis. J Rheumatol 37(2):474PubMedCrossRef Boyd M, Specks U, Finkielman JD (2010) Accuracy of the ICD-9 code for identification of patients with Wegener's granulomatosis. J Rheumatol 37(2):474PubMedCrossRef
Metadaten
Titel
Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature
verfasst von
Sepideh Faez
Ann-Marie Lobo
Sebastian H. Unizony
John H. Stone
George N. Papaliodis
Lucia Sobrin
Publikationsdatum
01.01.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 1/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2558-6

Weitere Artikel der Ausgabe 1/2016

Clinical Rheumatology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.